Treatment of patients with lamivudine-resistant and adefovir dipivoxil-resistant chronic hepatitis B virus infection: is tenofovir the answer?
about
Antiviral drug resistance: mechanisms and clinical implicationsHepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype.The Mongolian Gerbil: A Robust Model of Helicobacter pylori-Induced Gastric Inflammation and Cancer.
P2860
Treatment of patients with lamivudine-resistant and adefovir dipivoxil-resistant chronic hepatitis B virus infection: is tenofovir the answer?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Treatment of patients with lam ...... tion: is tenofovir the answer?
@en
Treatment of patients with lam ...... tion: is tenofovir the answer?
@nl
type
label
Treatment of patients with lam ...... tion: is tenofovir the answer?
@en
Treatment of patients with lam ...... tion: is tenofovir the answer?
@nl
prefLabel
Treatment of patients with lam ...... tion: is tenofovir the answer?
@en
Treatment of patients with lam ...... tion: is tenofovir the answer?
@nl
P2093
P2860
P356
P1433
P1476
Treatment of patients with lam ...... tion: is tenofovir the answer?
@en
P2093
P2860
P304
436-7; author reply 437
P356
10.1136/GUT.2006.108928
P407
P577
2007-03-01T00:00:00Z